Loading...

SOHO 2026 Annual Meeting

1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

ePostersLive by SciGen Technologies S.A. All rights reserved.

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters

Showing 1,267 results.

Thumbnail for CPX-351 vs Standard of Care as Bridging to AlloHCT in Patients With Higher-Risk Myelodysplastic Neoplasms or Oligoblastic Acute Myeloid Leukemia: Results of the Randomized Phase 2 PALOMA Study

MPN - 756

CPX-351 vs Standard of Care as Bridging to AlloHCT in Patients With Higher-Risk Myelodysplastic Neoplasms or Oligoblastic Acute Myeloid Leukemia: Results of the Randomized Phase 2 PALOMA Study

Uwe Platzbecker

Poster Presenter: Uwe Platzbecker

Thumbnail for Risk Stratification and Overall Survival in Patients With Primary Myelofibrosis in Armenia: Real-World Data From a 10-Year Cohort

MPN - 788

Risk Stratification and Overall Survival in Patients With Primary Myelofibrosis in Armenia: Real-World Data From a 10-Year Cohort

Levon Evoyan

Poster Presenter: Levon Evoyan

Thumbnail for Characterizing the Humanistic Burden of Anemia Associated With Myelofibrosis Through Patient-Reported Outcomes: Findings from a Systematic Literature Review

MPN - 809

Characterizing the Humanistic Burden of Anemia Associated With Myelofibrosis Through Patient-Reported Outcomes: Findings from a Systematic Literature Review

Chelsea Norregaard

Poster Presenter: Chelsea Norregaard

Thumbnail for Cardiovascular Risk Burden and Thrombotic Outcomes in Essential Thrombocythemia: A 152-Patient Real-World Cohort with 8.6-Year Median Follow-Up

MPN - 821

Cardiovascular Risk Burden and Thrombotic Outcomes in Essential Thrombocythemia: A 152-Patient Real-World Cohort with 8.6-Year Median Follow-Up

Elmir Israfilov

Poster Presenter: Elmir Israfilov

Thumbnail for Update From the Phase 2 RESTORE Trial of Elritercept in Patients With Myelofibrosis Receiving Ruxolitinib

MPN - 832

Update From the Phase 2 RESTORE Trial of Elritercept in Patients With Myelofibrosis Receiving Ruxolitinib

Ciro Rinaldi

Poster Presenter: Ciro Rinaldi

Thumbnail for In-Hospital Mortality and 30-Day Readmissions in Patients With Myeloproliferative Neoplasm Hospitalized With NSTEMI: A Nationwide Analysis Stratified by Revascularization Strategy

MPN - 847

In-Hospital Mortality and 30-Day Readmissions in Patients With Myeloproliferative Neoplasm Hospitalized With NSTEMI: A Nationwide Analysis Stratified by Revascularization Strategy

Aishwarya Ramesh

Poster Presenter: Aishwarya Ramesh

Thumbnail for Clinical and Molecular Features of Adult-Onset KRAS-Mutant Leukoproliferative Disorder With Monocytosis

MPN - 850

Clinical and Molecular Features of Adult-Onset KRAS-Mutant Leukoproliferative Disorder With Monocytosis

Emma St Martin

Poster Presenter: Emma St Martin

Thumbnail for Efficacy of Midostaurin Therapy and Allogeneic Bone Marrow Transplantation in Patients With Advanced Systemic Mastocytosis

MPN - 855

Efficacy of Midostaurin Therapy and Allogeneic Bone Marrow Transplantation in Patients With Advanced Systemic Mastocytosis

Zarema Abdulkhalikova

Poster Presenter: Zarema Abdulkhalikova

Thumbnail for Urinary Mast Cell Metabolites Versus Serum Tryptase for Monitoring Clinical Response to Cytoreductive Therapy in Indolent Systemic Mastocytosis

MPN - 861

Urinary Mast Cell Metabolites Versus Serum Tryptase for Monitoring Clinical Response to Cytoreductive Therapy in Indolent Systemic Mastocytosis

Cecilia Arana-Yi

Poster Presenter: Cecilia Arana-Yi